Literature DB >> 13735285

Burn therapy. I. Concealed progress due to a shifting battlefront.

A W PHILLIPS, O COPE.   

Abstract

Keywords:  BURNS/therapy

Mesh:

Year:  1960        PMID: 13735285      PMCID: PMC1613728          DOI: 10.1097/00000658-196011000-00001

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


× No keyword cloud information.
  10 in total

1.  A survey of burns at the Vancouver General Hospital from 1946 to 1955.

Authors:  D E YATES; G B STILES; R J COWAN; R G LANGSTON
Journal:  Can Med Assoc J       Date:  1958-02-15       Impact factor: 8.262

2.  [Prognosis in severe burns; comparison of mortality in the years 1940 to 1944 and in 1950 to 1954].

Authors:  J TAPPEINER; W WITTELS
Journal:  Wien Klin Wochenschr       Date:  1956-05-25       Impact factor: 1.704

3.  Mortality of burns at the Massachusetts General Hospital, 1939-1954.

Authors:  B A BARNES
Journal:  Ann Surg       Date:  1957-02       Impact factor: 12.969

4.  Aging and mortality from thermal injury.

Authors:  C A MOYER
Journal:  J Gerontol       Date:  1954-10

5.  Infection in burns. III. Septicemia, a common cause of death.

Authors:  N C F LIEDBERG; E REISS; C P ARTZ
Journal:  Surg Gynecol Obstet       Date:  1954-08

6.  A study of mortality in a burns unit: a revised estimate.

Authors:  J P BULL; A J FISHER
Journal:  Ann Surg       Date:  1954-03       Impact factor: 12.969

7.  Factors influencing the morbidity and mortality in burns.

Authors:  E B HAY; T D CRONIN
Journal:  Am J Surg       Date:  1954-01       Impact factor: 2.565

8.  An assessment of the therapy of burns; a clinical study.

Authors:  C A MOYER
Journal:  Ann Surg       Date:  1953-05       Impact factor: 12.969

9.  A clinical and experimental evaluation of the influence of ACTH on the need for fluid therapy of the burned patient.

Authors:  J W RAKER; A WIGHT; A J D MICHEL; O COPE
Journal:  Ann Surg       Date:  1951-10       Impact factor: 12.969

10.  A Study of Mortality in a Burns Unit: Standards for the Evaluation of Alternative Methods of Treatment.

Authors:  J P Bull; J R Squire
Journal:  Ann Surg       Date:  1949-08       Impact factor: 12.969

  10 in total
  10 in total

1.  BURN THERAPY. IV. RESPIRATORY TRACT DAMAGE (AN ACCOUNT OF THE CLINICAL, X-RAY AND POSTMORTEM FINDINGS) AND THE MEANING OF RESTLESSNESS.

Authors:  A W PHILLIPS; J W TANNER; O COPE
Journal:  Ann Surg       Date:  1963-11       Impact factor: 12.969

2.  ANNOTATIONS.

Authors: 
Journal:  Br Med J       Date:  1962-05-12

3.  Burn therapy. II. The revelation of respiratory tract damage as a principal killer of the burned patient.

Authors:  A W PHILLIPS; O COPE
Journal:  Ann Surg       Date:  1962-01       Impact factor: 12.969

4.  Corticosteroid treatment of experimental smoke inhalation.

Authors:  D P Dressler; W A Skornik; S Kupersmith
Journal:  Ann Surg       Date:  1976-01       Impact factor: 12.969

5.  Review of pseudomonas sepsis in thermal burns: verdoglobin determination and gentamicin therapy.

Authors:  H H Stone
Journal:  Ann Surg       Date:  1966-02       Impact factor: 12.969

6.  The effects of short-term steroid therapy on lung bacterial clearance and survival in rats.

Authors:  W A Skornik; D P Dressler
Journal:  Ann Surg       Date:  1974-04       Impact factor: 12.969

7.  Effect of antimicrobial therapy on lung bacterial clearance in the burned rat.

Authors:  D P Dressler; W A Skornik
Journal:  Ann Surg       Date:  1972-02       Impact factor: 12.969

8.  Lung bacterial clearance in the burned rat.

Authors:  W A Skornik; D P Dressler
Journal:  Ann Surg       Date:  1970-11       Impact factor: 12.969

9.  Pathology, mortality and prognosis of burns: a review of 54 critical and fatal cases.

Authors:  R V Argamaso
Journal:  Can Med Assoc J       Date:  1967-08-26       Impact factor: 8.262

10.  Twenty-five year review of Pseudomonas aeruginosa bacteremia in a burn center.

Authors:  A T McManus; A D Mason; W F McManus; B A Pruitt
Journal:  Eur J Clin Microbiol       Date:  1985-04       Impact factor: 3.267

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.